1330.0000 -10.40 (-0.78%)
NSE Apr 07, 2026 15:51 PM
Volume: 1.6M
 

1330.00
-0.78%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Geojit BNP Paribas increased Buy price target of Aurobindo Pharma Ltd. to 1502.0 on 01 Apr, 2026.
More from Aurobindo Pharma Ltd.
Recommended